Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/29239
Title: Human recombinant erythropoietin gradient dosage influence on ischemic and reperfusion liver injury
Authors: Alehin, S. A.
Kolmykov, D. I.
Pokrovskii, M. V.
Keywords: medicine
pharmacology
human recombinant erythropoietin
ischemia
reperfusion
liver
blood flow
morphological changes
Issue Date: 2015
Citation: Alehin, S.A. Human recombinant erythropoietin gradient dosage influence on ischemic and reperfusion liver injury / S.A. Alehin, D.I. Kolmykov, M.V. Pokrovskii // Research Result: Pharmacology and Clinical Pharmacology. - 2015. - Vol.1, №1(1).-P. 9-12. - Doi: 10.18413/2500-235X-2015-1-4-9-14. - Refer.: p. 12.
Abstract: We investigate influence of human recombinant erythropoietin different dosage on blood flow velocity and morphological changes in liver during ischemic and reperfusion injury. It was proved what optimal preconditioning dosage is 50 IU/kg
URI: http://dspace.bsu.edu.ru/handle/123456789/29239
Appears in Collections:Research Result. Pharmacology and Clinical Pharmacology

Files in This Item:
File Description SizeFormat 
Alehin_Human.pdf1.3 MBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.